17 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Synthesis, in vitro evaluation and cocrystal structure of 4-oxo-[1]benzopyrano[4,3-c]pyrazole Cryptosporidium parvum inosine 5'-monophosphate dehydrogenase (CpIMPDH) inhibitors.
University of Houston
Binding of curcumin and its long chain derivatives to the activator binding domain of novel protein kinase C.
University of Houston
HIV-1 integrase pharmacophore model derived from diverse classes of inhibitors.
University of Houston
Binding of isoxazole and pyrazole derivatives of curcumin with the activator binding domain of novel protein kinase C.
University of Houston
Chemical modifications of resveratrol for improved protein kinase C alpha activity.
University of Houston
Linker optimization and activity validation of a cell surface vimentin targeted homo-dimeric peptoid antagonist for lung cancer stem cells.
University of Houston
Dynamic pharmacophore model optimization: identification of novel HIV-1 integrase inhibitors.
University of Houston
Dynamic receptor-based pharmacophore model development and its application in designing novel HIV-1 integrase inhibitors.
University of Houston
Design of pyrido[2,3-d]pyrimidin-7-one inhibitors of receptor interacting protein kinase-2 (RIPK2) and nucleotide-binding oligomerization domain (NOD) cell signaling.
University of Houston
Receptor-interacting protein kinase 2 (RIPK2) and nucleotide-binding oligomerization domain (NOD) cell signaling inhibitors based on a 3,5-diphenyl-2-aminopyridine scaffold.
University of Houston
Mycophenolic anilides as broad specificity inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitors.
University of Houston
Synthesis and activity of benzimidazole-1,3-dioxide inhibitors of separase.
University of Houston
Discovery of covalent enzyme inhibitors using virtual docking of covalent fragments.
University of Houston
Synthesis and activity of functionalizable derivatives of the serotonin (5-HT) 5-HT
University of Houston
Activation loop targeting strategy for design of receptor-interacting protein kinase 2 (RIPK2) inhibitors.
University of Houston
